An audit desk for a market that didn't have one.

Why we exist

The research-peptide market grew faster than the publications covering it could keep up. Most vendor reviews you can find are written by people the vendors paid — sometimes openly, more often as “influencer” arrangements buried in fine print.

Much of the evidence a buyer needs is already public, but scattered: lab certificates, FDA letters, court dockets, shop prices. We collect it, check vendor COAs against the labs' own records, and publish the result with dates and links. We have not placed first-hand test orders yet; when we do, the affected vendor pages will say so.

What we do

• Score every vendor we cover with the same public-data method, and re-read its records when they change.
• Publish vendor profiles, peptide guides, and head-to-head comparisons.
• Maintain a live coupon directory with verified, non-expired codes.
• Send one email a month with new audits and pruned coupons.

What we don't do

• Sell peptides. We are a publication, not a vendor.
• Provide medical advice or recommend dosing for human use.
• Accept retainers, sponsored content, or paid feature placements.
• Allow vendors to review their audits before publication.

The team

Editorial is a small team of writers and one analyst running the audits. We have no lab partner yet. The lab results we cite come from public lab records, and each one names the lab that issued it.

Most contributors write under pen names. The grey-market context makes real-name bylines impractical for the writers and risky for the labs. The tradeoff is real and we'd rather work pseudonymously than not at all.

Contact

For corrections, tips on vendors we should audit, or pitches: tips@vialaudit.com. For affiliate program inquiries: partnerships@vialaudit.com. On LinkedIn: linkedin.com/company/vialaudit.